Antonio E Barberio
Overview
Explore the profile of Antonio E Barberio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
94
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barberio A, Smith S, Pires I, Iyer S, Reinhardt F, Melo M, et al.
Bioeng Transl Med
. 2023 Mar;
8(2):e10453.
PMID: 36925719
Ovarian cancer is especially deadly, challenging to treat, and has proven refractory to known immunotherapies. Cytokine therapy is an attractive strategy to drive a proinflammatory immune response in immunologically cold...
2.
Barberio A, Smith S, Correa S, Nguyen C, Nhan B, Melo M, et al.
ACS Nano
. 2020 Jul;
14(9):11238-11253.
PMID: 32692155
Although cytokine therapy is an attractive strategy to build a more robust immune response in tumors, cytokines have faced clinical failures due to toxicity. In particular, interleukin-12 has shown great...
3.
Correa S, Boehnke N, Barberio A, Deiss-Yehiely E, Shi A, Oberlton B, et al.
ACS Nano
. 2020 Jan;
14(2):2224-2237.
PMID: 31971772
Nanoparticle surface chemistry is a fundamental engineering parameter that governs tumor-targeting activity. Electrostatic assembly generates controlled polyelectrolyte complexes through the process of adsorption and charge overcompensation utilizing synthetic polyions and...
4.
Dreaden E, Kong Y, Quadir M, Correa S, Suarez-Lopez L, Barberio A, et al.
Bioeng Transl Med
. 2018 Jan;
3(1):26-36.
PMID: 29376131
DNA damaging chemotherapy is a cornerstone of current front-line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will...